Entrada Therapeutics Inc. (TRDA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entrada Therapeutics Inc.

    NASDAQ: TRDA · Real-Time Price · USD
    6.00
    0.08 (1.35%)
    At close: Oct 03, 2025, 1:27 PM

    Entrada Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 210.78M 129.01M n/a n/a
    Cost of Revenue
    		 n/a 99.88M 1.9M 1.12M
    Gross Profit
    		 210.78M 29.13M -1.9M -1.12M
    Operating Income
    		 47.01M -3.16M -97.25M -51.13M
    Interest Income
    		 19.47M 15.22M 2.63M n/a
    Pretax Income
    		 66.48M 12.06M -94.62M -51.16M
    Net Income
    		 65.63M -6.68M -87.46M -50.07M
    Selling & General & Admin
    		 38.47M 32.29M 30.64M 15.2M
    Research & Development
    		 125.31M 99.88M 66.61M 35.93M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 163.77M 132.18M 97.25M 51.13M
    Interest Expense
    		 n/a n/a 2.63M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 163.77M 132.18M 97.25M 51.13M
    Income Tax Expense
    		 859K 18.74M -7.16M -1.09M
    Shares Outstanding (Basic)
    		 37.31M 33.05M 31.29M 31.22M
    Shares Outstanding (Diluted)
    		 39M 33.05M 31.29M 31.22M
    EPS (Basic)
    		 1.76 -0.2 -2.79 -1.6
    EPS (Diluted)
    		 1.68 -0.2 -2.79 -1.6
    EBITDA
    		 47.01M -321K -95.35M -50.01M
    EBIT
    		 47.01M -3.16M -97.25M -51.16M
    Depreciation & Amortization
    		 n/a 2.84M 1.9M 1.12M

    Add to Watchlist